title: Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
authors.affiliation: Department of Surgery, University of Chicaog, Illinois 60637, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: J B
authors.initials: JB
authors.lastname: Piper
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
authors.forename: D S
authors.initials: DS
authors.lastname: Seaman
authors.forename: A L
authors.initials: AL
authors.lastname: Baker
authors.forename: J
authors.initials: J
authors.lastname: Hart
authors.forename: K
authors.initials: K
authors.lastname: Dasgupta
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
mesh_terms: D000328:Adult; D001706:Biopsy; D004334:Drug Administration Schedule; D004351:Drug Resistance; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D016559:Tacrolimus